Minimize Uncertainty – Make Informed Decisions – Succeed

Endocrinology

Endocrinology Today—February 24, 2026

February 24, 2026Portal Diabetes,Portal Pump,genetics,University of Queensland,artificial intelligence,Physics-Informed Machine Learning,FDA,HypoxyStat,astrazeneca,Cell Metabolism,BioPharma and Tech News,Tirzepatide,NICE,GLP-1 Receptor Agonists,Endocrinology News,Dapagliflozin,Continuous Glucose Monitoring,ForxigaSGLT2 Inhibitors,Menopausal Hormone Therapy

This week's Endocrinology update covers guideline and labeling changes,…

by LucidQuest

Obesity Weekly News

Obesity Today—February 24, 2026

February 24, 2026wegovy,semaglutide,BioPharma and Tech News,Novo Nordisk,Tirzepatide,Zepbound,Eli Lilly,type 2 diabetes,GLP-1 receptor agonist,Obesity NewsMetabolic syndrome,Calibrate

This week's Obesity update highlights regulatory decisions, late-stage clinical…

by LucidQuest

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Angelini Pharma collaboration with Quiver Bioscience on genetic epilepsies

February 24, 2026market access,clinical development,neuroscience,rare disease,biopharma,epilepsy,licensing,Lucid Diligence Brief,diligence,AI drug discoveryantisense oligonucleotide

Lucid Diligence Brief: Angelini Pharma collaboration with Quiver Bioscience on…

by Timos Papagatsias

Hematology

Hematology Video Recap—February 23, 2026

February 23, 2026ProteoCharts,Foghorn Therapeutics,astrazeneca,Disc Medicine,sanofi,Bitopertin,BioPharma and Tech News,Iberdomide,Rilzabrutinib,Relapsed or Refractory Multiple Myeloma,Ono Pharmaceutical,Calquence,Bristol Myers Squibb,Tirabrutinib,Hematology News,Zenyaku Kogyo,Chugai Pharmaceutical,Rituxan,chronic lymphocytic leukemia,Autoimmune Hemolytic Anemia,Erythropoietic protoporphyria,Primary Central Nervous System Lymphoma,warm autoimmune hemolytic anemiaSenti Biosciences,Yatiri Bio

Hematology biweekly video covering key regulatory actions and clinical program…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Gilead to acquire Arcellx (anito-cel)

February 23, 2026Oncology,FDA,Regulatory,Cell Therapy,Multiple Myeloma,CAR T,biopharma,Lucid Diligence Brief,payer access,diligence,M&A,manufacturingCVR

Lucid Diligence Brief: Gilead to acquire Arcellx (anito-cel) Professional…

by Timos Papagatsias

Hematology

Hematology Today—February 23, 2026

February 23, 2026STAR-LLD,Faron Pharmaceuticals,astrazeneca,Omeros,Sickle Cell Disease,OncotoX-AML,BioPharma and Tech News,Calquence,bexmarilimab,Pharmac New Zealand,Ono Pharmaceutical,Tirabrutinib,Bristol Myers Squibb,Fulcrum Therapeutics,Acute Myeloid Leukemia,Pociredir,Hematology News,Zenyaku Kogyo,chronic lymphocytic leukemia,Rituxan,TuHURA Biosciences,Autoimmune Hemolytic Anemia,Primary Central Nervous System Lymphoma,IberdomideRelapsed or Refractory Multiple Myeloma,Starton Therapeutics

This week's Hematology update covers key regulatory actions and clinical…

by LucidQuest

Onco_background

Oncology Today—February 23, 2026

February 23, 2026RET Fusion-Positive Non-Small Cell Lung Cancer,HER2-Positive Early Breast Cancer,roche,Estrogen Receptor-Positive Breast Cancer,BioPharma and Tech News,Zanidatamab,Eli Lilly,HER2-Positive Biliary Tract Cancer,ENHERTU,Johnson & Johnson,Daiichi Sankyo,giredestrant,Oncology News,Non-muscle invasive bladder cancer,EGFR-mutated non-small cell lung cancer,Rybrevant FASPRO,ImmunityBioANKTIVA,Retevmo

This week's Oncology update covers  a mix of regulatory actions, filing…

by LucidQuest

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Hims & Hers to acquire Eucalyptus

February 22, 2026digital health,market access,telehealth,GLP-1,Lucid Diligence Brief,M&A,integration,consumer health platform,international expansion,regulatory risk,unit economicsearnouts

Lucid Diligence Brief: Hims & Hers to acquire Eucalyptus Professional…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Candel Therapeutics $100m funding for CAN-2409 in localized prostate cancer

February 21, 2026clinical trials,market access,reimbursement,gene therapy,FDA,prostate cancer,biopharma,Lucid Diligence Brief,capital markets,oncolytic virus,commercialization,royalty financingventure diligence

Lucid Diligence Brief: Candel Therapeutics $100m funding for CAN-2409 in…

by Timos Papagatsias

Public_Health

Public Health Today—February 20, 2026

February 20, 2026Alzheimer's Disease,BioPharma and Tech News,Chikungunya,Gut Brain Axis,p-tau217,Public Health News,Intermittent fasting,probiotics,PM2.5 air pollution,PFASDMT therapy,sleep deprivation

This weekly Public Health update covers major research and population-health…

by LucidQuest

Vaccines_News

Vaccines Video Recap—February 20, 2026

February 20, 2026Mexico,gsk,sanofi,Arexvy,Moderna,BioPharma and Tech News,COVID-19,Aptar Pharma,Vaccine news,influenza,Respiratory syncytial virus infection,Delonix Bioworks,Meningococcal Disease Serogroup BDynavax,Nasal Vaccines

This biweekly Vaccines video recap summarizes key developments across…

by LucidQuest

Vaccines

Vaccines Today—February 20, 2026

February 20, 2026gsk,Moderna,BioPharma and Tech News,mpox,mrna vaccines,RSV Vaccine,GeoVax,COVID-19 vaccine,Vaccine news,polio vaccineintranasal vaccine,vaccine delivery systems

This week's Vaccines update summarizes key developments including regulatory…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.